Scarica l'app Stockscreener
31.06
9.34%
-3.20
Dopo l'orario di chiusura:
31.05
-0.010
-0.03%
Precedente Chiudi:
$34.26
Aprire:
$31.01
Volume 24 ore:
571.65K
Relative Volume:
3.10
Capitalizzazione di mercato:
$443.29M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
-3.12%
1M Prestazione:
+39.03%
6M Prestazione:
+83.03%
1 anno Prestazione:
-32.58%
Intervallo 1D:
$27.22
$31.48
Intervallo di 1 settimana:
$27.22
$35.47
Portata 52W:
$6.875
$74.49
Neurogene Inc Stock (NGNE) Company Profile
Nome
Neurogene Inc
Settore
Industria
Telefono
(877) 237-5020
Indirizzo
535 W 24TH STREET, NEW YORK
Confronta NGNE con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NGNE
Neurogene Inc
|
31.06 | 488.96M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Neurogene Inc Stock (NGNE) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-17 | Iniziato | Craig Hallum | Buy |
| 2025-05-16 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2024-06-27 | Iniziato | BMO Capital Markets | Outperform |
| 2024-06-11 | Iniziato | Robert W. Baird | Outperform |
| 2024-04-29 | Iniziato | Leerink Partners | Outperform |
| 2024-03-21 | Iniziato | William Blair | Outperform |
| 2024-01-08 | Iniziato | H.C. Wainwright | Buy |
| 2024-01-05 | Iniziato | Stifel | Buy |
| 2024-01-04 | Iniziato | TD Cowen | Outperform |
Mostra tutto
Neurogene Inc Borsa (NGNE) Ultime notizie
How to use a screener to detect Neurogene Inc. breakoutsJuly 2025 Price Swings & Consistent Growth Equity Picks - newser.com
Is Neurogene Inc. stock a buy on dipsWeekly Earnings Recap & Safe Entry Momentum Tips - newser.com
Why Neurogene Inc. (UU8) stock could be top winnerQuarterly Performance Summary & Risk Adjusted Swing Trade Ideas - newser.com
Tools to monitor Neurogene Inc. recovery probabilityTrade Exit Summary & Consistent Growth Stock Picks - newser.com
Applying big data sentiment scoring on Neurogene Inc.2025 Trade Ideas & Fast Entry Momentum Trade Alerts - newser.com
Is Neurogene Inc. (UU8) stock among top earnings playsDip Buying & Safe Swing Trade Setups - newser.com
Using AI based signals to follow Neurogene Inc.Trade Analysis Summary & Safe Capital Growth Trade Ideas - newser.com
Can Neurogene Inc. (UU8) stock sustain institutional flowsQuarterly Performance Summary & Low Risk High Win Rate Stock Picks - newser.com
Will Neurogene Inc. (UU8) stock profit from automation waveJuly 2025 Pullbacks & Proven Capital Preservation Tips - newser.com
Why Neurogene Inc. stock could outperform in 2025July 2025 Recap & High Conviction Buy Zone Picks - newser.com
Will Neurogene Inc. stock outperform growth indexesEarnings Growth Summary & Verified Momentum Watchlists - newser.com
Why Neurogene Inc. stock is popular among millennialsEarnings Trend Report & Weekly Breakout Watchlists - newser.com
Why Neurogene Inc. stock remains a top recommendationWeekly Investment Summary & Risk Adjusted Buy/Sell Alerts - newser.com
Signal strength of Neurogene Inc. stock in tech scanners2025 Volume Leaders & Free Verified High Yield Trade Plans - newser.com
Risk adjusted return profile for Neurogene Inc. analyzedEntry Point & Long-Term Capital Growth Strategies - newser.com
Does Neurogene Inc. qualify in momentum factor screeningBond Market & AI Based Buy/Sell Signal Reports - newser.com
Why Neurogene Inc. stock remains undervaluedPortfolio Value Report & AI Powered Market Trend Analysis - newser.com
Is Neurogene Inc. (UU8) stock supported by strong fundamentalsGlobal Markets & Stepwise Trade Execution Plans - newser.com
Will Neurogene Inc. (UU8) stock keep high P E multiplesPortfolio Return Summary & Expert Approved Momentum Trade Ideas - newser.com
Volume spikes in Neurogene Inc. stock – what they meanJuly 2025 Catalysts & Community Consensus Stock Picks - newser.com
Is Neurogene Inc. (UU8) stock a buy before new product rollout - newser.com
Price action breakdown for Neurogene Inc.July 2025 Sector Moves & Verified Swing Trading Watchlists - newser.com
Why Neurogene Inc. (UU8) stock could break out in 20252025 Trading Recap & Daily Profit Maximizing Tips - newser.com
Combining price and volume data for Neurogene Inc.July 2025 Closing Moves & Stepwise Entry/Exit Trade Alerts - newser.com
Neurogene Inc. $NGNE Shares Bought by Jennison Associates LLC - MarketBeat
Neurogene Inc Azioni (NGNE) Dati Finanziari
Non sono disponibili dati finanziari per Neurogene Inc (NGNE). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
0.64%
0.35%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):